Head and Neck Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect head and neck Cancer Information Center has current, evidence-based information for you. Get the facts about head and neck cancer early detection, treatment, and survivorship, and stay up to date with ongoing head and neck cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Head & Neck Cancer Community is the leading Social Media Application for Head & Neck Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
Advaxis, Inc. (ADXS), a clinical-stage biotechnology company developing cancer immunotherapies,... Keytruda® Approved for Advanced Head and Neck Cancer
The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab)... Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer
Patients with head and neck cancer who comply with their scheduled radiation treatments...
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
Head and Neck Cancer Management
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer... Pay it Forward
Survivors become peer mentors to newly diagnosed women and offer experience, insight,...
Head and Neck Cancer Clinical Trials
GOG0522 – A Randomized, Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) (Followed by Surgery in Selective Patients) for Stage III and IV Head and neck Carcinomas
20020402 – A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Receiving Radiotherapy With Concurrent Chemotherapy (RT/CT)
INST0612C – Relationship of Mucositis Severity to Nutrition Intake in Head and Neck Cancer Patients